Fox Run Management’s Atea Pharmaceuticals AVIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$53.4K Buy
+10,245
New +$52.4K 0.01% 921

Other funds holding AVIR

Fox Run Management's AVIR Position: Q3 2026 in Review

Fox Run Management opened a new position in Atea Pharmaceuticals (AVIR) in Q3 2026: 10,245 shares worth $53.4K. The stake represents 0.01% of the portfolio and ranks #921 among its holdings.

126 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.

  • Fox Run Management held 10,245 shares of Atea Pharmaceuticals worth $53.4K as of Q3 2026.
  • Atea Pharmaceuticals was a new Fox Run Management position in Q3 2026.
  • Atea Pharmaceuticals made up 0.01% of Fox Run Management's portfolio in Q3 2026, its #921 holding.
  • 126 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.

Based on Fox Run Management's 13F filing for Q3 2026, filed 12 Nov 2026.